Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8059836 | 0.97 | TSHR (0.37) | TSHRALDH1A1MEN1KMT2ATHRB | |
| Trimethylammonium SCHEMBL10711048 | 0.95 | TSHR (0.36) | TSHRALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL27129415 | 0.91 | TSHR (0.43) | TSHRALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL791330 | 0.85 | ALDH1A1 (0.39) | TSHRALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL43803 | 0.85 | TSHR (0.46) | TSHRALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL28578541 | 0.83 | TSHR (0.44) | TSHRALDH1A1MEN1KMT2ATHRB | |
| Hydrochloric Acid SCHEMBL1132203 | 0.83 | TSHR (0.44) | TSHRALDH1A1MEN1KMT2ATHRB | |
| Bromide SCHEMBL1835574 | 0.83 | TSHR (0.44) | TSHRALDH1A1MEN1KMT2ATHRB | |
| Ammonia Solution, Strong SCHEMBL2637823 | 0.83 | TSHR (0.44) | TSHRALDH1A1MEN1KMT2ATHRB | |
| SCHEMBL27982484 | 0.83 | TSHR (0.44) | TSHRALDH1A1MEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1545 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204609-B1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4720199-A1 | SELF-CROSSLINKABLE URETHANE (METH)ACRYLATES | ARKEMA France (FR) | 2026-04-08 | — | — | EP | claimed |
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | MACDERMID ENTHONE INC (US) | 2026-03-19 | — | — | US | claimed |
| CN-118345204-B | Amphoteric ion type environment-friendly organic chromium-free tanning agent and preparation method thereof | 齐鲁工业大学(山东省科学院) | 2026-02-27 | — | — | CN | claimed |
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | SHOFU INC. (JP) | 2026-02-17 | — | — | US | claimed |
| WO-2025264382-A1 | COLLECTOR COMPOSITION FOR ORE BENEFICIATION | ArrMaz Products Inc. (US) | 2025-12-26 | — | — | WO | claimed |
| EP-4667107-A1 | COLLECTOR COMPOSITION FOR ORE BENEFICIATION | ArrMaz Products Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| US-12441694-B2 | Process for the preparation of methylene blue | DISHMAN CARBOGEN AMCIS LTD. (IN) | 2025-10-14 | — | — | US | claimed |
| US-12359125-B2 | Silicon etchant composition, pattern formation method and manufacturing method of array substrate using the etchant composition, and array substrate manufactured therefrom | DONGWOO FINE-CHEM CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| CN-120192499-A | Antibacterial aqueous polyurethane material, preparation method thereof and application thereof in preparation of medical catheter | 淮安凯悦科技开发有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-4759861-A | Consists of an aliphatic mono- or di-carboxylic acid, a dimer or trimer of said dicarboxylic acid, petroleum sulfonic acid and naphthenic acid or salt | NIPPON OIL CO., LTD. (JP) | 1988-07-26 | — | — | US | claimed |
| US-4740452-A | DIHYDROXYBENZENE-TYPE DEVELOPER, SULFITE PRESERVATIVE, AND AMINE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-26 | — | — | US | claimed |
| EP-0256896-A2 | Cerium alcanolatoamines | RHONE-POULENC CHIMIE (FR) | 1988-02-24 | — | — | EP | claimed |
| EP-0203521-A2 | A process for preparing negative images | FUJI PHOTO FILM CO., LTD. (JP) | 1986-12-03 | — | — | EP | claimed |
| US-4626529-A | AMINE-NEUTRALIZED ANIONIC SURFACTANT | L'OREAL (FR) | 1986-12-02 | — | — | US | claimed |
| US-4545965-A | ABSORPTION WITH AN ANHYDROUS OSLUTION OF A TERITARY AMINE AND AN O | SNAMPROGETTI, S.P.A. (IT) | 1985-10-08 | — | — | US | claimed |
| US-4506091-A | Removal of catalyst residues from polyesters | TEKNOR APEX COMPANY A DE CORP | 1985-03-19 | — | — | US | claimed |
| US-4488564-A | Oily composition intended for the treatment of keratin substances and the skin | L'OREAL (FR) | 1984-12-18 | — | — | US | claimed |
| US-4406868-A | ABSORPTION WITH ALKANOAMINES | PHILLIPS PETROLEUM COMPANY (US) | 1983-09-27 | — | — | US | claimed |
| US-4016115-A | Unsaturated polyester resin composition containing titanium dioxide | TOYO BOSEKI KABUSHIKI KAISHA (JA) | 1977-04-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441694-B2 | Process for the preparation of methylene blue | B2M, LMNB2, LMNA | TSHR 1699/4885ALDH1A1 2170/4885MEN1 208/4885 |
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | AOC2, HCN2, STMN2 | TSHR 2486/4885ALDH1A1 30/4885MEN1 979/4885 |
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | CDH1, DCLRE1A, ITGA1 | TSHR 3987/4885ALDH1A1 50/4885MEN1 2636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.